Improves access to orphan drugs for patients with rare diseases by identifying therapeutics in development or limited markets and enabling international supply and market access. Uses a data‑science platform that aggregates pharmaceutical data across 75+ countries and 6,000 sources to support rare-disease detection and successful drug launches.